Scientific Documentation

Access a wealth of knowledge with Roquette's scientific documentation, whitepapers, case studies, webinars and much more. Our scientific resources page offers in-depth insights into our research, innovative solutions, and real-world applications. Stay informed and enhance your understanding of the latest developmentsthrough our comprehensive and expert-driven content.

Scientists in a lab setting looking at a tablet

Items / page

Order by

Filter

Items / page

Order by

Pharma (176)

Case Studies (57)
Formulation Guidelines (49)
The Science Behind (8)
Troubleshooting (16)
Webinars (28)
White Papers (18)

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Chewable Tablets with XYLISORB^® XTAB 400 Xylitol

Directly compressible formulation for placebo chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Mint flavor Orodispersible Tablets with Mannitol

Directly compressible formulation for placebo orodispersible tablets (ODT)

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Mint Flavor Chewable Tablets with PEARLITOL^® 200 SD Mannitol

Directly compressible formulation for a mint flavor placebo chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Hard Chewable Tablets Using PEARLITOL^® 200 SD Mannitol and XYLISORB^® XTAB 240 Xylitol

Directly compressible formulation for placebo hard chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Hard Chewable Tablets Using PEARLITOL^® 200 SD Mannitol and XYLISORB^® 300 Xylitol

Directly compressible formulation for placebo hard chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Chewable Tablets with XYLISORB^® XTAB 400 Xylitol

Directly compressible formulation for placebo chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

Sugarless Pastilles with LYCASIN^® Maltitol, PEARLITOL^® Mannitol and Gum Arabic

Formulation for sugarless pastilles that contain LYCASIN® 80/55 Maltitol Liquid, PEARLITOL® 160 C Mannitol and Gum Arabic

Pharma

Formulation Guidelines

Published January 28, 2026

Sweetpearl^® P90 Maltitol and KLEPTOSE^® Linecaps Pea Maltodextrin Placebo Granules

Placebo formulation demonstrating processability of SweetPearl® P90 Maltitol as filler/binder and KLEPTOSE® Linecaps Pea Maltodextrin in high shear wet granulation process

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Chewable Tablets with XYLISORB^® XTAB 400 Xylitol

Directly compressible formulation for placebo chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Chewable Tablets with PEARLITOL^® 200 SD Mannitol

Directly compressible formulation for placebo chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

Placebo Chewable Tablets with NEOSORB^® P 300 C Sorbitol and SweetPearl^® P200 Maltitol

Directly compressible formulation for placebo chewable tablets

Pharma

Formulation Guidelines

Published January 28, 2026

PEARLITOL^® 50 C Mannitol and LYCATAB^® DSH Maltodextrin Placebo

Placebo formulation demonstrating processability of PEARLITOL® 50 C Mannitol as filler/binder and LYCATAB® DSH Maltodextrin as binder in high shear wet granulation process

Pharma

Formulation Guidelines

Published January 28, 2026

Orange Flavor B-complex Chewable Tablets with NEOSORB^® P 300 C Sorbitol and MICROCEL^® MC-102 Microcrystalline Cellulose

The B-complex is a combination of eight water soluble vitamins: thiamine, riboflavin, niacin, pantothenic acid, biotin, pyridoxine, folate and cobalamin.

Pharma

Formulation Guidelines

Published January 28, 2026

Nutraceutical Guarana Orodispersible Tablets with PEARLITOL^® Flash Mannitol, Starch

Directly compressible formulation for Guarana Orodispersible Tablets (ODT)

Pharma

Formulation Guidelines

Published January 28, 2026

Multivitamin Suckable Tablet formulation for direct compression

Directly compressible formulation of multivitamin suckable tablets using NEOSORB® P 300 C sorbitol as filler-binder